Go Back
June, 2023
Pluronic® P123-coated liposomal codelivery of paclitaxel and lapatinib enhances therapeutic potential via tumor cell targeting and overcoming multidrug resistance in triple-negative breast cancer cells
https://scholar9.com/publication-detail/pluronic-p123-coated-liposomal-codelivery-of-pacl--39051
Details
Volume
13
ISSN
2231-3354
Dr Subrahmanyam Pitchika
"Pluronic® P123-coated liposomal codelivery of paclitaxel and lapatinib enhances therapeutic potential via tumor cell targeting and overcoming multidrug resistance in triple-negative breast cancer cells".
Journal of Applied Pharmaceutical Science,
vol: 13,
Jun. 2023, https://scholar9.com/publication-detail/pluronic-p123-coated-liposomal-codelivery-of-pacl--39051